Trial Profile
Phase I clinical trial of monoclonal antibody ch14.18 [APN 311] in paediatric patients with recurrent/refractory neuroblastoma.
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 14 Jul 2016
Price :
$35
*
At a glance
- Drugs Dinutuximab beta (Primary)
- Indications Neuroblastoma
- Focus Adverse reactions
- 07 Jun 2016 Results (n=10) presented at the 52nd Annual Meeting of the American Society of Clinical Oncology
- 02 Apr 2015 New trial record